1. AB0275 One-Year Treatment Patterns and Healthcare Resource Use Among Patients with Rheumatoid Arthritis Newly Initiating Treatment with Biologic Dmards. (9th June 2015) Authors: Harnett, J.; Gerber, R.; Gruben, D.; Wiederkehr, D.; Mahgoub, E.Y.; Wallenstein, G.; Koenig, A. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 984 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cardiac safety of tiotropium in patients with COPD: a combined analysis of Holter‐ECG data from four randomised clinical trials. Issue 1 (11th December 2014) Authors: Hohlfeld, J. M.; Furtwaengler, A.; Könen‐Bergmann, M.; Wallenstein, G.; Walter, B.; Bateman, E. D. Journal: International journal of clinical practice Issue: Volume 69:Issue 1(2015) Page Start: 72 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FRI0178 Estimated Medical Expenditures among Patients with Rheumatoid Arthritis Undergoing Treatment with Tofacitinib, an Oral Janus Kinase Inhibitor. (10th June 2014) Authors: Rendas-Baum, R.; Kosinski, M.; Singh, A.; Mebus, C.; Wilkinson, B.; Riese, R.; Wallenstein, G. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 446 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. FRI0575 The Unmet Need in The Norwegian Disease-Modifying Antirheumatic Drug Registry. (15th July 2016) Authors: Olsen, I.C.; Kvien, T.K.; Lie, E.; Vasilescu, R.; Wallenstein, G.; Strengholt, S. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 649 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OP0152 Effects of Tofacitinib Monotherapy versus Methotrexate on Patient-Reported Outcomes in the 2-Year Phase 3 Oral Start TRIAL in Methotrexate-NaÏVe Patients with Rheumatoid Arthritis. (10th June 2014) Authors: Alten, R.; Strand, V.; Fleischmann, R.; Koncz, T.; Zwillich, S.; Bradley, J.; Gruben, D.; Wilkinson, B.; Krishnaswami, S.; Wallenstein, G. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. SAT0115 Tofacitinib Versus Biologic Treatments in Patients with Active Rheumatoid Arthritis Who have had an Inadequate Response to Tumour Necrosis Factor Inhibitors - A Network Meta-Analysis. (23rd January 2014) Authors: Vieira, M. C.; Wallenstein, G.; Bradley, J.; Gruben, D.; Koncz, T.; Zwillich, S. H.; Jansen, J. P. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A619 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. SAT0165 Tofacitinib versus Biologic Treatments in Moderate To Severe Rheumatoid Arthritis Patients Who Have Had An Inadequate Response To Nonbiologic Dmards: Systematic Literature Review and Network Meta-Analysis. (15th July 2016) Authors: Bergrath, E.; Wallenstein, G.; Gerbert, R.; Gruben, D.; Makin, C. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 726 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. SAT0256 Tofacitinib with and without methotrexate versus adalimumab with methotrexate for the treatment of rheumatoid arthritis: patient-reported outcomes from a phase 3b/4 randomised trial. (12th June 2018) Authors: Strand, V.; Mysler, E.; Moots, R.J.; Wallenstein, G.; DeMasi, R.; Gruben, D.; Soma, K.; Iikuni, N.; Fleischmann, R. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 990 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. SAT0348 The Economic Value of Tofacitinib 5 Mg Bid in the Treatment of Moderate to Severe Rheumatoid Arthritis: A Canadian Analysis. (9th June 2015) Authors: Woolcott, J.C.; Blackhouse, G.; Claxton, L.; Wallenstein, G.; Tran, T.; Goeree, R.; Taylor, M.; Moynagh, D.; Singh, A. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 785 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. THU0132 Comparative Effectiveness of TNFI and Tofacitinib Monotherapy in Clinical Practice: Results from Corrona Registry. (15th July 2016) Authors: Reed, G.W.; Gerber, R.A.; Shan, Y.; Takiya, L.; Dandreo, K.J.; Gruben, D.; Kremer, J.M.; Wallenstein, G. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 228 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗